Within 3 days post alloSCT, IL-15 KO recipients developed rapid weight loss (Figure 1A) and high clinical GVHD scores (Figure 1B), and had to be killed by day 6 due to hyperacute GVHD. Here, IL15 is linked to graft versus host disease.